Skip to content

Office-Based Asthma Screening Intervention

Office-Based Asthma Screening Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00156468
Enrollment
365
Registered
2005-09-12
Start date
2003-10-31
Completion date
2005-09-30
Last updated
2011-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Interventions

BEHAVIORALProvider Prompt

Sponsors

Halcyon Hill Foundation
CollaboratorOTHER
Robert Wood Johnson Foundation
CollaboratorOTHER
University of Rochester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children ages 2-12 * Children arriving for an office visit in two Rochester, NY pediatric clinics * Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion criteria

* Children arriving at the office visit with an adult that is not their parent or guardian * Children arriving at the office visit with a parent or guardian that does not speak English * Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)

Design outcomes

Primary

MeasureTime frame
Preventive Medication Actions (PMA) taken by the provider at the time of the child's visit. A PMA is defined as a new medication prescription or change in medication dose.

Secondary

MeasureTime frame
Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026